MEK/MAPK pathway was analyzed in ES cells with disruption of MEK/MAPK or PI3K pathways via insulin growth factor-1 receptor (IGF-1R) neutralizing antibodies being associated with functional consequences including delayed time to primary tumor development and attenuated growth [41]. Here, MAP2K7 is linked to neoplasm.